About AMEDD - AMEDD Innovations Since Desert Storm

US Army sponsored a 6-year trial resulting in a combination vaccine that demonstrated the first ever success in preventing HIV infection with a 31% efficacy rate.  This study provided proof of concept that an HIV vaccine is possible.  Time magazine deemed this vaccine strategy the 2nd leading medical discovery of 2009 and number 8 in best inventions of the year.  The trial result has re-energized the HIV vaccine field scientifically and organizationally.  The Military HIV Research Program (MHRP) is at the front of the battle against HIV to protect US troops from infection and to reduce the global impact of the disease.  Although its primary focus is developing a globally effective HIV-1 vaccine, the program provides prevention, care and treatment through the President’s Emergency Plan for AIDS Relief (PEPFAR).  The program’s network includes international laboratory and clinical research capabilities.  MHRP’s main laboratories are in Rockville, Maryland, with research sites in Tanzania, Kenya, Nigeria, Uganda and Thailand.